NCT01579682

Brief Summary

Anorexia Nervosa (AN) has the highest mortality rate compared to any other psychiatric disorder. The most promising treatment for adolescents with AN is family-based treatment (FBT). However, only 50% of patients receiving FBT fully remit at 12-month follow-up. Consequently, providing an alternative therapy early in the treatment course for those not responding to FBT may enhance overall outcome. This study aims to develop a new treatment - Intensive Family-Focused Treatment (IFT) - to improve outcomes in those adolescents, aged 12-18 years, who do not show an early response to FBT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2012

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 18, 2012

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

April 13, 2016

Status Verified

April 1, 2016

Enrollment Period

4.3 years

First QC Date

April 5, 2012

Last Update Submit

April 12, 2016

Conditions

Keywords

Eating DisorderAnorexia NervosaEating Disorder Not Otherwise SpecifiedMaudsleyFamily-Based TherapyFBTFamily Therapy

Outcome Measures

Primary Outcomes (1)

  • Full remission from AN (%MBW>95)

    Weight restoration to at least 95% of Median body weight (calculated by height, weight, gender, and age)

    End of Treatment (6 months)

Secondary Outcomes (1)

  • Changes in subscale scores of the EDE

    End of Treatment (6 months)

Study Arms (2)

Psychotherapy

EXPERIMENTAL

Family-Based Therapy (12 sessions)

Behavioral: Family-Based Therapy (FBT)

Family-Based Therapy with Intensive Family-Focused Treatment

EXPERIMENTAL

The patient will receive 4 sessions of Family-Based therapy, and if the participant does not make adequate weight gain within this time period, will be assigned to Intensive Family-Focused Therapy (IFT).

Behavioral: Family-Based Therapy with Intensive Family-Focused treatment

Interventions

12 sessions of FBT over the course of 6 months.

Psychotherapy

FBT for 4 weeks then Intensive Family-Focused treatment (IFT) should the participant not make adequate weight progress within the time frame.

Family-Based Therapy with Intensive Family-Focused Treatment

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Meets DSM-IV criteria for anorexia nervosa
  • Lives with at least one English-speaking parent who is willing to participate
  • Medically Stable
  • Adequate transportation to clinic
  • Proficient at speaking, reading, and writing English

You may not qualify if:

  • Previous FBT for AN
  • Medical condition that may affect eating or weight

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Stanford University

Stanford, California, 94305, United States

Location

University of Chicago

Chicago, Illinois, 60637, United States

Location

Related Links

MeSH Terms

Conditions

Anorexia NervosaFeeding and Eating Disorders

Condition Hierarchy (Ancestors)

Mental DisordersSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • James D Lock, MD, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Daniel LeGrange, PhD

    University of Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 5, 2012

First Posted

April 18, 2012

Study Start

September 1, 2011

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

April 13, 2016

Record last verified: 2016-04

Locations